Susquehanna International Group, LLP Pro Phase Labs, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 64,906 shares of PRPH stock, worth $48,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,906
Previous 62,478
3.89%
Holding current value
$48,679
Previous $261,000
39.85%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PRPH
# of Institutions
27Shares Held
1.71MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA656KShares$491,9600.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny215KShares$161,3320.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL179KShares$134,2830.0% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$120,5510.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL82.9KShares$62,1990.11% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $12M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...